Skip to main content
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1968 Mar 9;98(10):505–507.

Nephrotic syndrome induced by penicillamine.

J Stein, H A Smythe
PMCID: PMC1923905  PMID: 5645186

Full text

PDF
505

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ADAMS D. A., GOLDMAN R., MAXWELL M. H., LATTA H. NEPHROTIC SYNDROME ASSOCIATED WITH PENICILLAMINE THERAPY OF WILSON'S DISEASE. Am J Med. 1964 Feb;36:330–336. doi: 10.1016/0002-9343(64)90096-8. [DOI] [PubMed] [Google Scholar]
  2. CORCOS J. M., SOLER-BECHARA J., MAYER K., FREYBERG R. H., GOLDSTEIN R., JAFFE I. NEUTROPHILIC AGRANULOCYTOSIS DURING ADMINISTRATION OF PENICILLAMINE. JAMA. 1964 Jul 27;189:265–268. doi: 10.1001/jama.1964.03070040015003. [DOI] [PubMed] [Google Scholar]
  3. COSTANZI J. J., COLTMAN C. A., Jr, CLARK D. A., TENNENBAUM J. I., CRISCUOLO D. CRYOBLOBULINEMIA ASSOCIATED WITH A MACROGLOBULIN; STUDIES OF A 17.5S CRYOPRECIPITATING FACTOR. Am J Med. 1965 Jul;39:163–172. doi: 10.1016/0002-9343(65)90256-1. [DOI] [PubMed] [Google Scholar]
  4. CRAWHALL J. C., SCOWEN E. F., WATTS R. W. Effect of penicillamine on cystinuria. Br Med J. 1963 Mar 2;1(5330):588–590. doi: 10.1136/bmj.1.5330.588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. GOLDBERG A., SMITH J. A., LOCHHEAD A. C. Treatment of lead-poisoning with oral penicillamine. Br Med J. 1963 May 11;1(5340):1270–1275. doi: 10.1136/bmj.1.5340.1270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Harris E. D., Jr, Sjoerdsma A. Effect of penicillamine on human collagen and its possible application to treatment of scleroderma. Lancet. 1966 Nov 5;2(7471):996–999. doi: 10.1016/s0140-6736(66)92926-6. [DOI] [PubMed] [Google Scholar]
  7. JAFFE I. A. Comparison of the effect of plasmapheresis and penicillamine on the level of circulating rheumatoid factor. Ann Rheum Dis. 1963 Mar;22:71–76. doi: 10.1136/ard.22.2.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. LEVENE C. I., GROSS J. Alterations in state of molecular aggregation of collagen induced in chick embryos by beta-aminopropionitrile (lathyrus factor). J Exp Med. 1959 Nov 1;110:771–790. doi: 10.1084/jem.110.5.771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Lotz M., Potts J. T., Jr, Holland J. M., Kiser W. S., Bartter F. C. D-penicillamine therapy in cystinuria. J Urol. 1966 Feb;95(2):257–263. doi: 10.1016/S0022-5347(17)63443-8. [DOI] [PubMed] [Google Scholar]
  10. RITZMANN S. E., COLEMAN S. L., LEVIN W. C. The effect of some mercaptanes upon a macrocryogelglobulin; modifications induced by cysteamine, penicillamine and penicillin. J Clin Invest. 1960 Aug;39:1320–1329. doi: 10.1172/JCI104149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. RITZMANN S. E., LEVIN W. C. Effect of mercaptanes in cold agglutinin disease. J Lab Clin Med. 1961 May;57:718–732. [PubMed] [Google Scholar]
  12. SCHEINBERG I. H. D-PENICILLAMINE, WITH PARTICULAR RELATION TO WILSON'S DISEASE. J Chronic Dis. 1964 Apr;17:293–298. doi: 10.1016/0021-9681(64)90071-2. [DOI] [PubMed] [Google Scholar]
  13. STERNLIEB I., SCHEINBERG I. H. PENICILLAMINE THERAPY FOR HEPATOLENTICULAR DEGENERATION. JAMA. 1964 Sep 7;189:748–754. doi: 10.1001/jama.1964.03070100042008. [DOI] [PubMed] [Google Scholar]
  14. WALSHE J. M. Penicillamine, a new oral therapy for Wilson's disease. Am J Med. 1956 Oct;21(4):487–495. doi: 10.1016/0002-9343(56)90066-3. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES